Search

Novavax Inc

Fechado

SetorSaúde

10.09 1.2

Visão Geral

Variação de preço das ações

24h

Atual

Mín

9.75

Máximo

10.14

Indicadores-chave

By Trading Economics

Rendimento

-44M

-53M

Vendas

-83M

57M

P/E

Médio do Setor

3.112

56.432

EPS

-0.32

Margem de lucro

-94.16

Funcionários

749

EBITDA

-39M

-40M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+12.1% upside

Dividendos

By Acuity

Próximos Ganhos

5 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

363M

1.6B

Abertura anterior

8.89

Fecho anterior

10.09

Sentimento de Notícias

By Acuity

50%

50%

120 / 339 Ranking em Healthcare

Novavax Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

18 de set. de 2026, 20:06 UTC

Novavax Inc shares are higher in Friday's trading session, recovering from mid-morning lows and maintaining a position above the 20-day moving average.

17 de set. de 2026, 20:02 UTC

Novavax Inc is advancing, continuing sharp gains since Wednesday, despite earlier pulling back from a session high amid broader market weakness.

16 de set. de 2026, 23:21 UTC

Novavax Inc's stock is modestly lower in after-market trading, following earlier volatility and currently trading below its 20-day moving average.

15 de set. de 2026, 22:51 UTC

Novavax Inc. shares are lower in after-market hours, reflecting broader economic concerns following a decline in the NY Empire State Manufacturing Index.

14 de set. de 2026, 23:36 UTC

Novavax shares are trading lower in after-market hours, following a broader decline in U.S. stocks amid rising crude oil prices and supply concerns.

11 de set. de 2026, 20:08 UTC

Novavax Inc. shares are higher during Friday's session, having reached a session high earlier before pulling back. No specific news was identified.

10 de set. de 2026, 23:01 UTC

Novavax Inc. shares are lower in after-market hours, continuing recent downward trends. The stock reached its lowest point shortly after the market reopened.

9 de set. de 2026, 19:46 UTC

Social Media

Novavax Inc shares are lower amid ongoing volatility following first-quarter results. The stock has faced pressure, dipping below $11.50 earlier in the session.

8 de set. de 2026, 19:26 UTC

Novavax Inc. shares are trading roughly flat, reflecting minimal change since Friday's close amid broader market trends. The asset remains above its 20-day moving average.

4 de set. de 2026, 23:15 UTC

Novavax Inc. shares are lower in after-market hours, reflecting a slight decline since Friday's close amid rising Treasury yields and interest rate expectations.

3 de set. de 2026, 23:05 UTC

Novavax Inc. shares are lower in after-market trading, despite remaining above their 20-day moving average and showing significant gains from a month ago.

2 de set. de 2026, 23:06 UTC

Novavax Inc. shares are trading roughly flat in after-market hours, with no specific news identified. The stock remains above its 20-day moving average.

1 de set. de 2026, 23:31 UTC

Novavax Inc. shares are lower in after-market trading, showing volatility since Tuesday's close, though the stock remains well above its 20-day moving average.

31 de ago. de 2026, 23:01 UTC

Novavax Inc shares are higher in after-market trading, continuing a strong three-session performance. No specific news was identified to explain the movement.

28 de ago. de 2026, 23:01 UTC

Novavax Inc shares declined in after-market trading, amid rising market expectations for an interest rate hike and upward pressure on Treasury yields.

27 de ago. de 2026, 23:01 UTC

Novavax Inc. shares are higher in after-market trading, rebounding from earlier volatility and remaining above the 20-day moving average.

26 de ago. de 2026, 20:08 UTC

Novavax Inc shares are lower as the biotechnology sector declines. The stock rebounded earlier in the session but has since pulled back.

25 de ago. de 2026, 20:07 UTC

Novavax Inc shares are higher Tuesday, supported by lower Treasury yields. The stock pulled back from an intraday high but remains up since Monday.

24 de ago. de 2026, 20:04 UTC

Novavax shares are lower today, reflecting broader market trends, with no specific company news identified. The stock remains above its 20-day moving average.

21 de ago. de 2026, 23:31 UTC

Novavax Inc. shares declined in after-market trading, moving within a narrow range since Friday's close. The stock remains above its 20-day moving average.

20 de ago. de 2026, 19:02 UTC

Macro Event

Novavax shares are trading lower amid negative jobless claims data, reflecting broader market fluctuations and a significant decline since Wednesday's close.

19 de ago. de 2026, 23:51 UTC

Novavax Inc. shares are lower in after-market hours amid broader declines in biotechnology stocks, despite an earlier session peak above Wednesday's close.

17 de ago. de 2026, 19:36 UTC

Novavax Inc is trading higher, reaching a session peak earlier today. The stock remains at the upper end of its one-month trading range.

14 de ago. de 2026, 23:26 UTC

Novavax Inc. shares are trading roughly flat in after-market hours, remaining above the 20-day moving average and near the upper end of the one-month range.

13 de ago. de 2026, 19:16 UTC

Novavax Inc. shares are higher today, maintaining strength above the 20-day moving average despite rising initial jobless claims reported by the Labor Department.

12 de ago. de 2026, 23:31 UTC

Novavax Inc. shares are lower in after-market trading, reflecting a weaker trend despite earlier gains. The stock remains above its 20-day moving average.

11 de ago. de 2026, 23:51 UTC

Novavax Inc. shares are higher in after-market trading, maintaining a position above the 20-day moving average within its one-month trading range.

10 de ago. de 2026, 23:46 UTC

Novavax Inc. shares are lower in after-market trading, showing some volatility since Monday's close and remaining within the middle of their one-month trading range.

7 de ago. de 2026, 19:36 UTC

News

Novavax Inc shares are higher today, supported by $57 million in second-quarter revenue and ongoing discussions with Sanofi on a COVID-19/influenza vaccine.

6 de ago. de 2026, 23:01 UTC

News

Novavax Inc expects 2026 revenue of $235 million to $275 million. Shares are trading higher in after-market hours following the earnings call.

Comparação entre Pares

Variação de preço

Novavax Inc Previsão

Preço-alvo

By TipRanks

12.1% parte superior

Previsão para 12 meses

Média 11.333 USD  12.1%

Máximo 18 USD

Mínimo 7 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Novavax Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

3 ratings

1

Comprar

1

Manter

1

Vender

Sentimento

By Acuity

120 / 339 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.